StockData
Pharvaris N.V. logo

Pharvaris N.V. (PHVS) stock

PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Apr 2, 2026Score 4/30
$32.28−0.16 (-0.49%)

Close on Nov 17, 2026Market cap $2.11BP/E –Yield –

Pharvaris net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2021 it was -€42.70M.

Annual net income

PeriodPeriod endValueChange
FY2021Dec 31, 2021-€42.70M–
FY2020Dec 31, 2020-€25.99M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2023Jun 30, 2023-€21.90M–
Q2 FY2022Jun 30, 2022-€12.71M–
Q2 FY2021Jun 30, 2021-€15.20M–

More Pharvaris figures

See a number that looks wrong?